Hybrid Manufacturing Approach

Our robust and diverse manufacturing system includes both internal manufacturing and outsourcing to Contract Manufacturing Organizations (CMOs).

While solid and topical dosage forms are manufactured in-house at our state-of-the-art facilities, for other dosage forms we leverage a network of strategic CMOs in the US, Europe/Switzerland and Japan. These CMOs are carefully selected based on their expertise and quality standards. This dual approach to manufacturing allows us to maintain a steady supply of pharmaceutical products to meet the needs of patients worldwide.